article thumbnail

World Parkinson’s Day 2023 and Promising Parkinson’s Disease Treatments

XTalks

By avoiding the stomach entirely, there is increased bioavailability and more sustained relief from symptoms. In terms of novel treatment options, the ASPro-PD Phase III trial is investigating ambroxol’s (ambroxol hydrochloride) potential to slow the progression of Parkinson’s disease.

article thumbnail

Considerations for Neuroscience Trials with Intrathecal Delivery and Other Methods of Direct CNS Administration

XTalks

Clinical research experts from the CRO Medpace shared insights about the operational and regulatory considerations for neuroscience trials with direct CNS administration. Why is it Difficult to Develop CNS Therapeutics?

Trials 83
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

New Phase 3 Data Show TAK-620 (maribavir), an Investigational Drug for the Treatment of Transplant Recipients with Refractory/Resistant Cytomegalovirus (CMV) Infections, Meets Primary Endpoint

The Pharma Data

The TAK-620-303 (SOLSTICE) trial (NCT02931539) is a multicenter, randomized, open-label, active-controlled trial comparing eight weeks of treatment with either maribavir or investigator assigned treatment (IAT) in transplant recipients with CMV infection refractory or resistant to existing antiviral treatments (i.e., About Maribavir.

Drugs 52
article thumbnail

ProstaStream

The Pharma Data

Because after many years of personal trials and experiments, I believe that I have finally discovered a special blend of ingredients which may help anyone support healthy prostate. If you are pregnant, nursing, taking medication, or have a medical condition, consult your physician before using our products.